Search alternatives:
linear decrease » linear increase (Expand Search)
lower decrease » larger decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
linear decrease » linear increase (Expand Search)
lower decrease » larger decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
6201
F05 demonstrates additive anti-tumor effects in combination with mAb therapy and reprograms M2 macrophages towards a phagocytotic phenotype.
Published 2025“…CD163 MFI is significantly decreased with F05 treatment (p = 0.0089, 55% decrease), but not 1H9 (p = 0.0828, 31% decrease) when compared to RITUX.…”
-
6202
-
6203
-
6204
Average wellness for matchday, MD
Published 2025“…<div><p>Background</p><p>Exposure to match loads significantly affects physiological and psychological indicators and, consequently, players’ wellness. …”
-
6205
The RehaGait® system.
Published 2025“…</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”
-
6206
Flow chart of included patients and dropouts.
Published 2025“…</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”
-
6207
Dataset of the analyzed data.
Published 2025“…</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”
-
6208
-
6209
Tuning curve sharpening and familiarity suppression.
Published 2025“…Both learning rules result in a statistically significant decrease in the SI. …”
-
6210
ERI Thresholds Between Adjacent Zones.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6211
Location of the study area.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6212
Random Forest structure with cross-validation.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6213
Land use change from 1990 to 2020.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6214
Geographic data.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6215
Classification accuracy.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6216
Identification of VHL as a novel E3 ubiquitin ligase for Vpx.
Published 2025“…Data are presented as mean ± standard deviation (SD) (n = 2). Statistical significance was evaluated using a two-tailed unpaired <i>t</i>-test. …”
-
6217
BrdU assay in control siRNA (blue bars) and in PAX6 knockdown (red bars) limbal epithelial cells (LECs) without and after 1µM or 5µM RA incubation for 48 hours.
Published 2025“…<p>Two-way ANOVA, followed by Dunnett’s test was used. Significant p values (<0.05) are highlighted. BrdU assay shows a significantly lower proliferation rate in the PAX6 siRNA knockdown group than in control siRNA group (p < 0.001). 5µM RA treatment significantly decreased proliferation rate in controls (p = 0.025). …”
-
6218
-
6219
-
6220